Neurol. praxi. 2016;17(5):320-322 | DOI: 10.36290/neu.2016.066
Use of pregabalin in clinical practice
- Neurologické oddělení, Městská nemocnice Ostrava
Pain in diabetic polyneuropathy is a pharmacologically difficult-to-manage condition that tends to be resistant to treatment with both non-steroidal anti-inflammatory drugs and common analgesics. Antidepressants and antiepileptics are the first-choice drugs. Pregabalin is an antiepileptic drug derived from gabapentin that has been shown to reduce the intensity of neuropathic pain (Richter et al., 2005). It is a structural lipophilic GABA analogue, which readily crosses the blood-brain barrier. The mechanism of action likely involves an ability to bind to the α2 δ-subunit of a voltage-gated presynaptic calcium channel, by which pregabalin reduces the release of excitatory calcium into the cell. It is usually administered twice or three times daily at a total daily dose of 150–600 mg. It is generally well tolerated, with the most common adverse effects being vertigo, somnolence, and peripheral oedema.
Keywords: pregabalin, gabapentin, neuropathic pain, diabetic neuropathy, anxiety disorder
Published: November 7, 2016 Show citation
References
- Arroyo S, Anhut H, Kugler A, Lee CM, Knapp LE, Garofalo EA, Messmer S; Pregabalin 1008-011 International Study Group. Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004; 45: 20-27.
Go to original source... 
Go to PubMed... - Beydoun AA, Uthman BM, Ramsey RE, Smith TM, Dumetz MK, Greiner MJ, Henkin S, Knapp LE, Garofalo EA, the Pregabalin 9/10 study group. Pregabalin add-on trial: double-blind, multicenter study in patients with partial epilepsy. Epilepsia 2000; 41(Suppl. 7): 253-254.
- Elger CE, Anhut H, Messmer S. Pregabalin add-on trial: a double-blind, placebo controlled, multicentre study to compare flexible- and fixed-dose treatment in refractory patients with partial seizures. Epilepsia 2004; 45(Suppl. 3): 67-68.
- Fink K, Doplet DJ, Meder WP, Suman-Chauhan N,Duffy S, Clusmann H, Göthert M. Inhibition of neuronal Ca influx by gabapentin and pregabalin in human neocortex. Neuropharmacology 2002; 42: 226-236. Go to original source... Go to PubMed...
- French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003; 60: 1631-1637. Go to original source... Go to PubMed...
- Novy J, Rossetti AO. Oral pregabalin as an add-on treatment for status epilepticus, 7 JUN 2010. Go to original source...
- Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005; 6: 253-260. Go to original source... Go to PubMed...
- Sharma U, Iacobellis D, Glessner C, et al. The Pregabalin 1008-14/29 Study Group. Pregabalin effectively relieves pain in two studies of patients with painful diabetic peripheral neuropathy (Studies 1008-14/29). Presented at the Meeting of the American Pain Society; November 2-5, 2000; Atlanta, GA, 2000.
- SPC. Souhrn údajů o přípravku: Lyrica (pregabalin), Pfizer, 8. 7. 2005.
- Suojaranta-Ylinen R, Hammarén E, Kontinen VK, Raivio P, Tarkkila P, Rosenberg PH. Pregabalin has an opioid-sparing effect in elderly patients after cardiac surgery: a randomized placebo-controlled trial. Survey of Anesthesiology; 2012: 56(4). Go to original source...
- Taylor CP, Vetanian MG. Profile of anticonvulsant activity of pregabalin in animal models. Epilepsia 1997; 38 (suppl 8): 35. Go to original source... Go to PubMed...
- Ziyaeifard M, Mehrabanian MJ, Faritus SZ, Khazaei Koohpar M, Ferasatkish R, Hosseinnejad H, Mehrabanian M, Premedication With Oral Pregabalin for the Prevention of Acute Postsurgical Pain in Coronary Artery Bypass Surgery, pub med jan/2015, online citation. Go to original source...